Svp, Cf Franchise Lead And Rct2100 Program Leader
Current
Feb 2024 - Present
AeroLeads people directory · profile
Heather Clark Email & Phone Number
SVP, CF Franchise Lead @ ReCode Therapeutics | Leading Global Drug Development
at
ReCode Therapeutics
1 work email found
@recodetx.com
14 phones found area 858, 619, 760, 334, 520, and 617
LinkedIn matched
✓ Verified May 2026
4 data sources
Profile completeness 100%
Current company
Role
SVP, CF Franchise Lead @ ReCode Therapeutics | Leading Global Drug Development
Location
San Diego, California, United States
Who is Heather Clark? Overview
A concise factual answer block for searchers comparing this professional profile.
Quick answer
Heather Clark is listed as SVP, CF Franchise Lead @ ReCode Therapeutics | Leading Global Drug Development at ReCode Therapeutics, based in San Diego, California, United States. AeroLeads shows a work email signal at recodetx.com, phone signal with area code 858, 619, 760, 334, 520, 617, and a matched LinkedIn profile for Heather Clark.
Heather Clark previously worked as SVP, CF Franchise Lead and RCT2100 Program Leader at Recode Therapeutics and VP, Program Management, CF Disease Area Lead at Recode Therapeutics. Heather Clark holds Master Of Science (M.S.), Protein And Structural Chemistry from University Of Arizona.
Company email context
Email format at ReCode Therapeutics
This section adds company-level context without repeating Heather Clark's masked contact details.
{first_initial}{last}@recodetx.com
86% confidence
AeroLeads found 1 current-domain work email signal for Heather Clark. Compare company email patterns before reaching out.
Profile bio
About Heather Clark
With over 26 years of experience in the pharmaceutical and biotech industries, I am a passionate and driven leader in rare disease drug development, with a career focus on cystic fibrosis (CF). As the SVP, CF Franchise Lead at ReCode Therapeutics, I oversee the global strategy and execution of our CF portfolio, which includes novel genetic therapies and RNA-based medicines for this life-threatening genetic disorder.My core competencies include drug discovery and development program management, portfolio management, alliance management, and strategic planning. I have successfully managed large collaborations and drug development program teams that have delivered 20 novel drug candidates to the clinic across multiple disease areas, and entered a new therapeutic market space with the first ever drug to treat the underlying cause of CF. I also played a key role in the acquisition of a phase 3 asset for Niemann Pick Type C, another rare disease with high unmet medical need. My mission is to leverage my expertise and network to bring innovative and transformative therapies to patients with rare diseases.Drug Development Program Manager for KALYDECO™, ORKAMBI™, SYMDEKO™ and TRIKAFTA™, VX-121 (Vanzacaftor™), VX-150, VTS-270 (Niemann-Pick Type C), RCT1100 (PCD), RCT2100 (CF)
Listed skills include Biotechnology, Drug Discovery, Pharmaceutical Industry, Drug Development, and 33 others.
Current workplace
Heather Clark's current company
Company context helps verify the profile and gives searchers a useful next step.
12 roles · 36 years
Heather Clark work experience
A career timeline built from the work history available for this profile.
Vp, Program Management, Cf Disease Area Lead
Apr 2022 - Feb 2024
Vp, Head Of Program Management
Mandos Health
Responsible for building corporate Program Management Office (PMO) as well leading Drug Development Program Management team for global Clinical Development programs. Transaction lead for acquisition of Phase 3 asset from Mallinckrodt for a Rare Disease.Therapeutic areas include Niemann Pick Type C, Cardiovascular Disease, Alzheimer’s and Dementia
Mar 2021 - Apr 2022
Head Of Program Management For Vertex San Diego, Director Of R&D Program Management
- Oversaw global R&D programs from early discovery research through mid-stage clinical development and planning of Phase III studies/product launch. Led the PM function at the Vertex San Diego site; established best.
- Managed discovery and early development teams that led to four (to date) drug products, KALYDECO™, ORKAMBI™, SYMDEKO™ and TRIKAFTA™, the first drugs in history to target the defective gene that causes Cystic Fibrosis.
- Managed discovery & early to mid-stage drug development of multiple drug candidates in clinical development, including entire portfolio CFTR Modulators and company's first novel pain program, one of the first in the.
- Managed large external drug discovery and development collaborations with CRISPR Tx, & Moderna with a focus on mRNA and CRISPR therapeutics for Cystic Fibrosis and other rare diseases.
- Lead Program and Alliance Manager for the 15 year duration of the Cystic Fibrosis Foundation research collaboration, resulting in Vertex’s portfolio of CF therapies, featured as a Harvard Business case study.
- Created Oracle-based system for tracking project progress, enabling provision of resourcing metrics for multiple collaborations and internal programs.
Aug 1999 - Mar 2021
Board Of Directors Member
Volunteer Leadership Initiative Chair 2008
Jan 2000 - 2012
Project Manager
- Project Manager Managed relationships and projects associated with external drug discovery collaborations involving major pharmaceutical companies, including Merck, Pfizer, BMS, J&J, Allergan, Glaxo, Lilly, Organon.
- Prepared for and led joint research meetings, steering committee meetings, and other collaborative meetings.
- Partnered with leaders of global project teams to ensure projects’ execution aligned with strategies and goals.
- Guided research groups through annual budget and forecasting process. Liaised with finance department to communicate project forecasts.
- Managed successful asset transfer of Aurora-based assay development tools (including GFP, Beta lactamase, and custom voltage sensing dyes) to Invitrogen (aka Life Technologies), following acquisition of Aurora by.
- Developed UHTS-compatible (3456-well) biochemical assays for internal drug discovery and 3456-well kinase assays.
1999 - 2001
~2 yrs
Researcher
GPCR Assay Development. Lead scientist in developing HTS assays, Medchem screening, and secondary hit follow-up. Developed GPCR ligand-binding and reporter gene assays. Assay development and HTS for multiple programs in Ferring’s Fertility, Obesity and Pain franchises. Radiation safety officer for pharmacology labs at San Diego site.
Feb 1998 - Aug 1999
Researcher
Pre-clinical drug investigation of a novel chemotherapeutic agent, partnered with Collagenex Pharmaceuticals. Investigated the application of a chemically modified non-antimicrobial tetracycline (CMT-3) against metastatic prostate cancer.
1996 - 1998
~2 yrs
Research/Quality Mgr
Responsible for the research, development and troubleshooting of problem components and instrumentation related to the Ion Selective Electrode Diagnostic technology for the Baxter Stratus II and Lytening I immunology analyzers. QC testing. GMP/GLP certified.
1996 - 1996
Graduate Research Associate
Area of study focused on physical inorganic chemistry and included structural analysis by NMR spectroscopy, as well as electrochemistry, protein abstraction and purification. Thesis pertained to the purification and the physical and structural characterization of the Nitrophorin 1 Heme protein of Rhodnius Prolixus, the "kissing bug", in the absence of a.
1993 - 1996
~3 yrs
Graduate Teaching Assistant
1993 - 1995
~2 yrs
Department Of Chemistry Research Assistant
1990 - 1993
~3 yrs
3 education records
Heather Clark education
Master Of Science (M.S.), Protein And Structural Chemistry
University Of Arizona
Bachelor Of Science (B.S.), Chemistry
Auburn University
Strategic Management
University Of Miami Herbert Business School
FAQ
Frequently asked questions about Heather Clark
Quick answers generated from the profile data available on this page.
What company does Heather Clark work for?
Heather Clark works for ReCode Therapeutics.
What is Heather Clark's role at ReCode Therapeutics?
Heather Clark is listed as SVP, CF Franchise Lead @ ReCode Therapeutics | Leading Global Drug Development at ReCode Therapeutics.
What is Heather Clark's email address?
AeroLeads has found 1 work email signal at @recodetx.com for Heather Clark at ReCode Therapeutics.
What is Heather Clark's phone number?
AeroLeads has found 14 phone signal(s) with area code 858, 619, 760, 334, 520, 617 for Heather Clark at ReCode Therapeutics.
Where is Heather Clark based?
Heather Clark is based in San Diego, California, United States while working with ReCode Therapeutics.
What companies has Heather Clark worked for?
Heather Clark has worked for Recode Therapeutics, Mandos Health, Vertex Pharmaceuticals, Cystic Fibrosis Foundation San Diego Chapter, and Aurora Bioscience.
How can I contact Heather Clark?
You can use AeroLeads to view verified contact signals for Heather Clark at ReCode Therapeutics, including work email, phone, and LinkedIn data when available.
What schools did Heather Clark attend?
Heather Clark holds Master Of Science (M.S.), Protein And Structural Chemistry from University Of Arizona.
What skills is Heather Clark known for?
Heather Clark is listed with skills including Biotechnology, Drug Discovery, Pharmaceutical Industry, Drug Development, Clinical Trials, Life Sciences, Assay Development, and Clinical Development.
Find 750M verified contacts
Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.
Start free trial